Skip to the content
Investors
Careers
Darklogo darklogo light
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Dark
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Dark
  • About Us
  • Innovations
    • Therapeutics
    • Diagnostics
      • Point of Care Use Cases
      • Key Innovations
      • Communication
      • SeekIt™
  • Seekers
  • Partnering
  • News
  • Contact Us
  • Investors
  • Careers
Diagnostics Featured

Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing

Seek Labs Awarded U.S. Patent for Isothermal Molecular Amplification Chemistry Designed for Decentralized Testing Newly issued patent covers foundational amplification chemistry de

Bridget Baldwin
May 7, 2026
0 Comments
Corporate Featured

Dr. Alison O’Mahony Named 2026 Mentor of the Year

Dr. Alison O’Mahony Named 2026 Mentor of the Year by BioHive April 28, 2026  Dr. Alison O’Mahony, Senior Vice President of Research and Development at Seek Labs, has been name

Bridget Baldwin
April 28, 2026
Corporate Featured

Jared Bauer Named Salt Lake City Titan 100 Honoree

Jared Bauer Named Salt Lake City Titan 100 2026 Honoree April 20, 2026 Jared Bauer, co-founder and CEO of Seek Labs, has been named a 2026 Salt Lake City Titan 100 honoree. The Tit

Bridget Baldwin
April 20, 2026
Corporate Featured

Seek Labs Joins BioMaP-Consortium to Support U.S. Biomanufacturing Preparedness Efforts

Seek Labs Joins BioMaP-Consortium to Support U.S. Biomanufacturing Preparedness Efforts As a member of the BioMaP-Consortium, Seek Labs gains access to a collaborative network adva

Bridget Baldwin
March 19, 2026
Blog Featured

For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics ​

For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics Highly pathogenic avian influenza (HPAI) illustrates a clear and urgent appli

Bridget Baldwin
March 11, 2026
Featured Therapeutics

Seek Labs Awarded $2M USDA Grant for CRISPR Avian Flu Therapeutic

Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based, Mutation-Resistant Therapeutic to Combat Avian Flu in Partnership with Canadian Food Inspection Agency USDA gra

Bridget Baldwin
February 17, 2026
Corporate Featured

2025 Innovation & Impact Report

Bridget Baldwin
December 23, 2025
Featured Therapeutics

Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats

Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats December 8, 2025 Read the full open-access review in Viruses Seek Lab

Bridget Baldwin
December 8, 2025
Therapeutics

CRISPR Treatments for AI-Designed Synthetic Viruses: Rapid Programmable Countermeasures for Emerging and Engineered Viruses

Bridget Baldwin
December 5, 2025
Veterinarian wearing biosecurity suit holding a pig inside a swine farm facility
Featured Therapeutics

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever

Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever November 17, 2025 SALT LAKE CITY, UT (Business Wire)

Bridget Baldwin
November 17, 2025

Posts pagination

1 2 3 4 5 6 7
350 W 800 N, Suite 220
Salt Lake City, UT 84103
  • About Us
  • Seekers
  • Contact Us
  • Investors
  • Quality Policy
  • Innovations
  • Therapeutics
  • Diagnostics

    By submitting this form, you agree to our Terms of Service and Privacy Policy.

    Multiple Patents Pending | Copyright 2023 All Rights Reserved

    Terms of Service | Privacy Policy

    BioSeeker, PTAP, and SeekIt are investigational platforms currently in preclinical development. Not cleared or approved by the FDA or any other regulatory agency..

    Back to top Drag